Treatment regimens for pregnant women with falciparum malaria

Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy

(2016) Brioni R. Moore et al.   DRUGS

Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study

(2016) Kerryn A Moore et al.   LANCET INFECTIOUS DISEASES

Four Artemisinin-Based Treatments in African Pregnant Women with Malaria

(2016)   NEW ENGLAND JOURNAL OF MEDICINE

Dihydroartemisinin–Piperaquine for the Prevention of Malaria in Pregnancy

(2016) Abel Kakuru et al.   NEW ENGLAND JOURNAL OF MEDICINE

Population Pharmacokinetics, Tolerability, and Safety of Dihydroartemisinin-Piperaquine and Sulfadoxine-Pyrimethamine-Piperaquine in Pregnant and Nonpregnant Papua New Guinean Women

(2015) John M. Benjamin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Artemether-Lumefantrine Pharmacokinetics and Clinical Response Are Minimally Altered in Pregnant Ugandan Women Treated for Uncomplicated Falciparum Malaria

(2015) Myaing M. Nyunt et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Opposite malaria and pregnancy effect on oral bioavailability of artesunate - a population pharmacokinetic evaluation

(2015) Frank Kloprogge et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Treating Severe Malaria in Pregnancy: A Review of the Evidence

(2015) Stephanie D. Kovacs et al.   DRUG SAFETY

A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy

(2015) Marcel Ukah et al.   INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS

Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin–piperaquine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial

(2015) Meghna Desai et al.   LANCET

Risks of miscarriage and inadvertent exposure to artemisinin derivatives in the first trimester of pregnancy: a prospective cohort study in western Kenya

(2015) Stephanie Dellicour et al.   MALARIA JOURNAL

Treatment policy change to dihydroartemisinin–piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes

(2015) Jeanne Rini Poespoprodjo et al.   MALARIA JOURNAL

Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort

(2015) Natthapon Laochan et al.   MALARIA JOURNAL

High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania

(2015) Vito Baraka et al.   MALARIA JOURNAL

Exposure to artemether-lumefantrine (Coartem®) in first trimester pregnancy in an observational study in Zambia

(2015) Christine Manyando et al.   MALARIA JOURNAL

Treatment of uncomplicated malaria with artesunate plus sulfadoxine-pyrimethamine is failing in Somalia: evidence from therapeutic efficacy studies andPfdhfrandPfdhpsmutant alleles

(2015) Marian Warsame et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Use of quantitative pharmacology tools to improve malaria treatments

(2015) Timothy M. E. Davis et al.   Expert Review of Clinical Pharmacology

Preliminary Study of Quinine Pharmacokinetics in Pregnant Women with Malaria-HIV Co-Infection

(2014) Kassoum Kayentao et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Improving the Role and Contribution of Pharmacokinetic Analyses in Antimalarial Drug Clinical Trials

(2014) Katherine Kay et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetics and Clinical Response for Artemether-Lumefantrine in Pregnant and Nonpregnant Women with Uncomplicated Plasmodium falciparum Malaria in Tanzania

(2014) Dominic Mosha et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Malaria: an update on current chemotherapy

(2014) Benjamin J Visser et al.   EXPERT OPINION ON PHARMACOTHERAPY

Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso

(2014) I. Valea et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Population pharmacokinetics of quinine in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda

(2014) F. Kloprogge et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort

(2014) Dominic Mosha et al.   MALARIA JOURNAL

Declining efficacy of artesunate plus sulphadoxine-pyrimethamine in northeastern India

(2014) Neelima Mishra et al.   MALARIA JOURNAL

Dihydroartemisinin-Piperaquine Treatment of Multidrug Resistant Falciparum and Vivax Malaria in Pregnancy

(2014) Jeanne Rini Poespoprodjo et al.   PLoS One

Medication exposure during pregnancy: a pilot pharmacovigilance system using health and demographic surveillance platform

(2014) Dominic Mosha et al.   BMC Pregnancy and Childbirth

Pharmacokinetic Properties of Artemether, Dihydroartemisinin, Lumefantrine, and Quinine in Pregnant Women with Uncomplicated Plasmodium falciparum Malaria in Uganda

(2013) Joel Tarning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Use of artemether–lumefantrine to treat malaria during pregnancy: what do we know and need to know?

(2013) Theonest K Mutabingwa et al.   Expert Review of Anti-Infective Therapy

MALARIA IN PREGNANCY

(2013) Ebako Ndip Takem et al.   Mediterranean Journal of Hematology and Infectious Diseases

Pharmacokinetics of Piperaquine in Pregnant Women in Sudan with Uncomplicated Plasmodium falciparum Malaria

(2012) Ishag Adam et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria

(2012) Joel Tarning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population Pharmacokinetic and Pharmacodynamic Modeling of Amodiaquine and Desethylamodiaquine in Women with Plasmodium vivax Malaria during and after Pregnancy

(2012) Joel Tarning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pregnancy and Fetal Outcomes After Exposure to Mefloquine in the Pre- and Periconception Period and During Pregnancy

(2012) P. Schlagenhauf et al.   CLINICAL INFECTIOUS DISEASES

Safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy: a systematic review

(2012) Christine Manyando et al.   MALARIA JOURNAL

Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India

(2012) Nicola Gargano et al.   MALARIA JOURNAL

Do patients adhere to over-the-counter artemisinin combination therapy for malaria? evidence from an intervention study in Uganda

(2012) Jessica L Cohen et al.   MALARIA JOURNAL

Population pharmacokinetics of Artemether and dihydroartemisinin in pregnant women with uncomplicated Plasmodium falciparum malaria in Uganda

(2012) Joel Tarning et al.   MALARIA JOURNAL

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan

(2012) Richard M Hoglund et al.   MALARIA JOURNAL

Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Falciparum Malaria

(2011) Marcus J. Rijken et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Amodiaquine and Desethylamodiaquine in Pregnant and Postpartum Women with Plasmodium vivax Malaria

(2011) Marcus J. Rijken et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Artesunate/dihydroartemisinin pharmacokinetics in acute falciparum malaria in pregnancy: absorption, bioavailability, disposition and disease effects

(2011) Rose McGready et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Malaria in pregnancy in the Asia-Pacific region

(2011) Marcus J Rijken et al.   LANCET INFECTIOUS DISEASES

Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study

(2011) R McGready et al.   LANCET INFECTIOUS DISEASES

Patterns of anti-malarial drug treatment among pregnant women in Uganda

(2011) Laura R Sangaré et al.   MALARIA JOURNAL

Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malaria

(2011) Carrie A Morris et al.   MALARIA JOURNAL

Update on genetic markers of quinine resistance in Plasmodium falciparum

(2011) John Okombo et al.   MOLECULAR AND BIOCHEMICAL PARASITOLOGY

Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy

(2011) R. Matthew Chico et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy

(2010) Esperança Sevene et al.   EXPERT OPINION ON PHARMACOTHERAPY

Prevention and treatment of malaria in pregnancy

(2010) Timothy ME Davis et al.   Future Microbiology

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

(2010) Arjen M Dondorp et al.   LANCET

Quinine for the treatment of malaria in pregnancy

(2010) R Matthew Chico et al.   LANCET INFECTIOUS DISEASES

Efficacy and safety of artemether–lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial

(2010) Patrice Piola et al.   LANCET INFECTIOUS DISEASES

Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia

(2010) Christine Manyando et al.   MALARIA JOURNAL

Quantifying the Number of Pregnancies at Risk of Malaria in 2007: A Demographic Study

(2010) Stephanie Dellicour et al.   PLOS MEDICINE

Population Pharmacokinetics of Lumefantrine in Pregnant Women Treated with Artemether-Lumefantrine for Uncomplicated Plasmodium falciparum Malaria

(2009) J. Tarning et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetic Properties of Sulfadoxine-Pyrimethamine in Pregnant Women

(2009) H. A. Karunajeewa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics of Sulfadoxine and Pyrimethamine in Intermittent Preventive Treatment of Malaria in Pregnancy

(2009) M M Nyunt et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Host immunity as a determinant of treatment outcome in Plasmodium falciparum malaria

(2009) Stephen J Rogerson et al.   LANCET INFECTIOUS DISEASES

Understanding the pharmacokinetics of Coartem®

(2009) Abdoulaye Djimdé et al.   MALARIA JOURNAL

Severe Embryotoxicity of Artemisinin Derivatives in Experimental Animals, but Possibly Safe in Pregnant Women

(2009) Qigui Li et al.   MOLECULES

Randomized Trial of Artesunate+Amodiaquine, Sulfadoxine-Pyrimethamine+Amodiaquine, Chlorproguanal-Dapsone and SP for Malaria in Pregnancy in Tanzania

(2009) Theonest K. Mutabingwa et al.   PLoS One

Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester

(2009) Robert L. Clark   REPRODUCTIVE TOXICOLOGY

Investigation of reproductive toxicity of piperaquine in mice

(2009) Kevin T. Batty et al.   REPRODUCTIVE TOXICOLOGY

New Medicines for Tropical Diseases in Pregnancy: Catch-22

(2008) Nicholas J White et al.   PLOS MEDICINE

A Randomised Controlled Trial of Artemether-Lumefantrine Versus Artesunate for Uncomplicated Plasmodium falciparum Treatment in Pregnancy

(2008) Rose McGready et al.   PLOS MEDICINE